REDPINE Medical, established in 2015 and based at Guangzhou International Bio-island, is committed to becoming a leading global provider of single-use endoscopes for integrated minimally invasive solutions across urology, gynecology, ENT, pneumology, gastroenterology, and general surgeries. The company operates in the Health Care industry and has garnered significant attention in the investment landscape. Notably, REDPINE Medical recently secured a Series C investment on 09 December 2022, with participation from prominent investors including Eight Roads Ventures, Tencent, Caixin Group, and Guangzhou Yuexiu Industrial Investment Fund.
General Information
BounceWatch is an independent company data service, not affiliated with REDPINE. To contact REDPINE, visit en.gzredpine.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
Health Care
About REDPINE
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed | €6.80M | 3 | 28 Apr 2026 | |
| Series C | Undisclosed | 4 | 09 Dec 2022 | |
| Series B | Undisclosed | 3 |
Guangxi Tencent Venture Capital, Taijiashan Jiankang Chanye Guquan Touzi Jijin +1
|
01 Oct 2021 |
| Series A | $15.20M | 1 | 21 Dec 2020 |
Latest News
View AllREDPINE Alternatives & Competitors
Endoso Endoscope Keeps Climbing, Never Stop.
Video Larynogscope, Bronchoscope, Ureteroscope,Rhinolaryngoscope,Cystoscope,Colonoscope and Duode...
More Than Healthcare, Human Care
FAQ About REDPINE
Source: BounceWatch company record for REDPINE, https://bouncewatch.com/company/redpine, updated 28 April 2026. When citing, please name BounceWatch and link this page.